These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10077333)

  • 1. Intrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids.
    Hua XY; Chen P; Marsala M; Yaksh TL
    Neuroscience; 1999 Mar; 89(2):525-34. PubMed ID: 10077333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of spinal neurokinin-1 and glutamate receptors in hyperalgesia and allodynia induced by prostaglandin E(2) or zymosan in the rat.
    Turnbach ME; Randich A
    Pain; 2002 May; 97(1-2):127-37. PubMed ID: 12031786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of spinal kainic acid receptor activation on spinal amino acid and prostaglandin E2 release in rat.
    Yang LC; Marsala M; Yaksh TL
    Neuroscience; 1996 Nov; 75(2):453-61. PubMed ID: 8931009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential roles of spinal neurokinin 1/2 receptors in development of persistent spontaneous nociception and hyperalgesia induced by subcutaneous bee venom injection in the conscious rat.
    Zheng JH; Chen J
    Neuropeptides; 2001 Feb; 35(1):32-44. PubMed ID: 11346308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of spinal protein kinase C blocks substance P-mediated hyperalgesia.
    Wajima Z; Hua XY; Yaksh TL
    Brain Res; 2000 Sep; 877(2):314-21. PubMed ID: 10986346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of spinal substance P and excitatory amino acids in inflammatory hyperalgesia in rats.
    Okano K; Kuraishi Y; Satoh M
    Jpn J Pharmacol; 1998 Jan; 76(1):15-22. PubMed ID: 9517400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonopioid actions of intrathecal dynorphin evoke spinal excitatory amino acid and prostaglandin E2 release mediated by cyclooxygenase-1 and -2.
    Koetzner L; Hua XY; Lai J; Porreca F; Yaksh T
    J Neurosci; 2004 Feb; 24(6):1451-8. PubMed ID: 14960618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal NK1 receptors contribute to the increased excitability of the nociceptive flexor reflex during persistent peripheral inflammation.
    Parsons AM; Honda CN; Jia YP; Budai D; Xu XJ; Wiesenfeld-Hallin Z; Seybold VS
    Brain Res; 1996 Nov; 739(1-2):263-75. PubMed ID: 8955947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SR 48968 specifically depresses neurokinin A- vs. substance P-induced hyperalgesia in a nociceptive withdrawal reflex.
    Yashpal K; Hui-Chan CW; Henry JL
    Eur J Pharmacol; 1996 Jul; 308(1):41-8. PubMed ID: 8836630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the tachykinin NK1 receptor antagonists, RP 67580 and SR 140333, on electrically-evoked substance P release from rat spinal cord.
    Malcangio M; Bowery NG
    Br J Pharmacol; 1994 Oct; 113(2):635-41. PubMed ID: 7530576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological contributions of neurokinin 1 receptor activation, and interactions with NMDA receptors, to inflammatory-evoked spinal c-Fos expression.
    Chapman V; Buritova J; Honoré P; Besson JM
    J Neurophysiol; 1996 Sep; 76(3):1817-27. PubMed ID: 8890294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1.
    Yaksh TL; Dirig DM; Conway CM; Svensson C; Luo ZD; Isakson PC
    J Neurosci; 2001 Aug; 21(16):5847-53. PubMed ID: 11487607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal phospholipase A2 in inflammatory hyperalgesia: role of the small, secretory phospholipase A2.
    Svensson CI; Lucas KK; Hua XY; Powell HC; Dennis EA; Yaksh TL
    Neuroscience; 2005; 133(2):543-53. PubMed ID: 15885922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of antinociception of spinal galanin: how does galanin inhibit spinal sensitization?
    Hua XY; Salgado KF; Gu G; Fitzsimmons B; Kondo I; Bartfai T; Yaksh TL
    Neuropeptides; 2005 Jun; 39(3):211-6. PubMed ID: 15944014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and intrathecal effects of a novel series of phospholipase A2 inhibitors on hyperalgesia and spinal prostaglandin E2 release.
    Yaksh TL; Kokotos G; Svensson CI; Stephens D; Kokotos CG; Fitzsimmons B; Hadjipavlou-Litina D; Hua XY; Dennis EA
    J Pharmacol Exp Ther; 2006 Jan; 316(1):466-75. PubMed ID: 16203828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal neurokinin3 receptors mediate thermal but not mechanical hyperalgesia via nitric oxide.
    Linden DR; Seybold VS
    Pain; 1999 Mar; 80(1-2):309-17. PubMed ID: 10204744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of intrathecal administration of RP67580, a potent neurokinin 1 antagonist on nociceptive transmission in the rat spinal cord.
    Chapman V; Dickenson AH
    Neurosci Lett; 1993 Jul; 157(2):149-52. PubMed ID: 8233046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal administration of prostaglandin E2 causes sensitization of the primary afferent neuron via the spinal release of glutamate.
    Ferreira SH; Lorenzetti BB
    Inflamm Res; 1996 Oct; 45(10):499-502. PubMed ID: 8912014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intrathecal injection of Sar9, Met(O2)11-substance P, neurokinin-1 receptor agonist, increases nitric oxide synthase expression and nitric oxide production in the rat spinal cord].
    Sun XC; Li WB; Li SQ; Li QJ; Chen XL; Ai J
    Sheng Li Xue Bao; 2003 Dec; 55(6):677-83. PubMed ID: 14695485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of spinal neurokinins, excitatory amino acids, proinflammatory cytokines, nitric oxide and prostanoids in pain facilitation induced by Phoneutria nigriventer spider venom.
    Zanchet EM; Longo I; Cury Y
    Brain Res; 2004 Sep; 1021(1):101-11. PubMed ID: 15328037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.